MIT Libraries logoDSpace@MIT

MIT
View Item 
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
  • DSpace@MIT Home
  • MIT Open Access Articles
  • MIT Open Access Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions

Author(s)
Chatterjee, Pranam; Ponnapati, Manvitha; Kramme, Christian; Plesa, Alexandru M.; Church, George M.; Jacobson, Joseph; ... Show more Show less
Thumbnail
DownloadPublished version (1.696Mb)
Publisher with Creative Commons License

Publisher with Creative Commons License

Creative Commons Attribution

Terms of use
Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/
Metadata
Show full item record
Abstract
The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has elicited a global health crisis of catastrophic proportions. With only a few vaccines approved for early or limited use, there is a critical need for effective antiviral strategies. In this study, we report a unique antiviral platform, through computational design of ACE2-derived peptides which both target the viral spike protein receptor binding domain (RBD) and recruit E3 ubiquitin ligases for subsequent intracellular degradation of SARS-CoV-2 in the proteasome. Our engineered peptide fusions demonstrate robust RBD degradation capabilities in human cells and are capable of inhibiting infection-competent viral production, thus prompting their further experimental characterization and therapeutic development.
Date issued
2020-11
URI
https://hdl.handle.net/1721.1/128692
Department
Massachusetts Institute of Technology. Center for Bits and Atoms; Massachusetts Institute of Technology. Media Laboratory
Journal
Communications Biology
Publisher
Springer Science and Business Media LLC
Citation
Chattergee, Pranam et al. "Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions." Communications Biology 3, 1 (November 2020): 715 © 2020 The Author(s)
Version: Final published version
ISSN
2399-3642

Collections
  • MIT Open Access Articles

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

Login

Statistics

OA StatisticsStatistics by CountryStatistics by Department
MIT Libraries
PrivacyPermissionsAccessibilityContact us
MIT
Content created by the MIT Libraries, CC BY-NC unless otherwise noted. Notify us about copyright concerns.